FDA officials argue over safety of new arthritis drug.

  • Ray Moynihan*
  • *Corresponding author for this work

Research output: Contribution to journalArticleProfessional

Fingerprint

Dive into the research topics of 'FDA officials argue over safety of new arthritis drug.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science